Disseminated Histoplasmosis Presenting as Urinary Tract Obstruction in a Renal Transplant Recipient

1994 ◽  
Vol 23 (4) ◽  
pp. 600-604 ◽  
Author(s):  
Keith R. Superdock ◽  
J. Stephen Dummer ◽  
Michael O. Koch ◽  
David M. Gilliam ◽  
David H. Van Buren ◽  
...  
2011 ◽  
Vol 12 (2) ◽  
pp. 163-165
Author(s):  
Tânia Mara L.B. Araújo ◽  
Geraldo B. Silva Junior ◽  
Orivaldo A. Barbosa ◽  
Rafael S.A. Lima ◽  
Elizabeth F. Daher

Histoplasmosis is an infectious disease caused by the dimorphic fungus Histoplasma capsulatum.. The disseminated form is usually found in immunocompromised patients. A 53 year-old man, renal transplant recipient, was admitted with fever, dyspnea, productive cough, adynamia and weight loss. He was septic, but hemodynamically stable. The tracheal aspirate found intracellular fungi and the peripheral blood exam was compatible with histoplasmosis. The patient presented a progressive worsening of respiratory pattern and needed mechanical ventilation, vasoactive drugs and hemodialysis. A large spectrum antimicrobial therapy was started, including amphotericin B, but the patient died. Keyword: Disseminated histoplasmosis. Kidney transplantation. Immunosuppression DOI: http://dx.doi.org/10.3329/jom.v12i2.7125 JOM 2011; 12(2): 163-165


Author(s):  
Rosario MD ◽  
◽  
Alfredo G-G ◽  
De Jesus AOA ◽  
Jorge AS ◽  
...  

Opportunistic infections are frequent complications after renal transplantation because of the use of immunosuppressants. Disseminated Histoplasmosis (DH) is one such opportunistic infection, and its clinical presentation varies, which makes its diagnosis a challenge. There is no information regarding DH as a cause of refractory thrombocytopenia in renal transplant recipient (RTR); therefore, we consider this an atypical case, and, because of its clinical characteristics, we have classified it as an Immune Thrombocytopenic Purpura (ITP) induced by histoplasmosis. This is the first case reported in our milieu, and it opens up the possibility for use of intravenous immunoglobulin as a strategic therapy for thrombocytopenia induced by HP in immunosuppressed RTRs.


2014 ◽  
Vol 13 (2) ◽  
pp. e1195
Author(s):  
A. Kalachyk ◽  
A. Narbin ◽  
P. Vershinin ◽  
M. Guberskaya ◽  
M. Kozlova ◽  
...  

1998 ◽  
Vol 27 (5) ◽  
pp. 1336-1336 ◽  
Author(s):  
A. Shirwany ◽  
S. J. Sargent ◽  
R. R. Dmochowski ◽  
M. S. Bronze

Sign in / Sign up

Export Citation Format

Share Document